# Atracurium Besylate

NDC: 71288-702
Generic name: Atracurium Besylate
Labeler / Manufacturer: Meitheal Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20180515

FDA application: ANDA091489

## Active ingredients

- ATRACURIUM BESYLATE: 10 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71288-702"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71288-702
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=efe90ee2-fe9e-421f-9e54-2961085d3b12